Clinical Trials Sponsored by Furesø Kommune

Total 2175 results

Forest Laboratories

Completed

A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

Eosinophilic Esophagitis

United States
Forest Laboratories

Completed

Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

Gastroparesis

Australia
Forest Laboratories

Completed

Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers

Healthy

United States
Forest Laboratories

Completed

Efficacy and Safety of Itopride vs Placebo in Heartburn

Heartburn

United States
Forest Laboratories

Completed

Effect of Azimilide Dihydrochloride on Renal Function

Healthy

United States
Forest Laboratories

Terminated

A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.

Coronary Artery Disease

United States
Forest Laboratories

Completed

A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures

Pain | Fissure in Ano
Forest Laboratories

Completed

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Bipolar 1 Disorder

United States, Bulgaria, Croatia, India, Philippines, Romania, Russian Federation, Serbia, Turkey, Ukraine
Forest Laboratories

Completed

Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)

Bipolar I Disorder

United States
Forest Laboratories

Completed

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Finland, Germany, Romania, Russian Federation, Serbia, Ukraine
Forest Laboratories

Withdrawn

Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

Anal Fissure

United States
Forest Laboratories

Terminated

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Estonia, Hungary, Iceland, Italy, Korea, Republic of, Serbia, Ukraine, Canada, Colombia, Belgium, France, New Zealand, Poland, South Africa, Spain
Forest Laboratories

Completed

Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

Healthy

United States
Forest Laboratories

Completed

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Staphylococcus Aureus Bacteremia | Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia

United States
Forest Laboratories

Completed

Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital

Infections

United States
Forest Laboratories

Completed

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Stage 2 Hypertension | Stage 1 Hypertension

United States
Forest Laboratories

Completed

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Exocrine Pancreatic Insufficiency: Cystic Fibrosis

United Kingdom, Italy, Belgium, Bulgaria, France, Germany, Poland
Forest Laboratories

Completed

A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)

Chronic Pancreatitis | Exocrine Pancreatic Insufficiency

United States, Italy, Ukraine
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder

Major Depressive Disorder

United States, Canada
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Hypertension

United States
Forest Laboratories

Terminated

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) (SHIELD-2)

Heart Diseases | Cardiovascular Diseases | Arrhythmias, Cardiac | Implantable Cardioverter Defibrillator

United States, Belgium, Canada, Czech Republic, Denmark, France, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden
Forest Laboratories

Unknown

Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

Hypertension

United States
Forest Laboratories

Completed

Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Forest Laboratories

Completed

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)

Stroke, Acute

United States, Austria, Australia, Canada, Finland, Germany, Netherlands, Spain
Forest Laboratories

Completed

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Schizophrenia

United States
Forest Laboratories

Completed

Nebivolol in Patients With Systolic Stage 2 Hypertension (NEB-MD-20)

Hypertension

United States
Forest Laboratories

Completed

Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.

Atrial Fibrillation

United States, Canada
Forest Laboratories

Completed

Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients

Hypertension

United States
Forest Laboratories

Completed

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

Fibromyalgia

United States
Forest Laboratories

Completed

A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Dementia of the Alzheimer's Type

United States, Argentina, Chile, Mexico
Forest Laboratories

Completed

A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy

Hypertension

United States
Forest Laboratories

Terminated

Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia

Fibromyalgia

United States
Forest Laboratories

Completed

Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

Major Depressive Disorder

United States
Forest Laboratories

Completed

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

Alzheimer's Disease

United States
Forest Laboratories

Completed

Study of Milnacipran for the Treatment of Fibromyalgia

Fibromyalgia

United States
Immune Oncology Research Institute
Agenus Inc.

Recruiting

Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)

Non-small Cell Lung Cancer

Armenia
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Recruiting

A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Recruiting

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Neoplasms | Neoplasms by Histologic Type

China
AC Immune SA
ICON Clinical Research

Recruiting

A Study to Evaluate the Effects of ACI-7104.056 Vaccination in Patients With Early Stages of Parkinson's Disease (VacSYn)

Parkinson Disease | Parkinson Disease 6, Early-Onset

United Kingdom, Spain, Germany
AC Immune SA
Worldwide Clinical Trials

Recruiting

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Alzheimer's Disease | Prodromal Alzheimer's Disease | Amyloid Plaque | Beta-Amyloid | Alzheimer's Disease in Down Syndrome

United States, Spain, United Kingdom
Mural Oncology, Inc
Immune Oncology Network

Completed

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Non-cutaneous Squamous Cell Carcinoma of Head and Neck

United States
Immune Design
Merck Sharp & Dohme LLC

Completed

Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1

Melanoma - Currently Enrolling | Non-small Cell Lung Cancer - Enrollment Completed | Sarcoma - Enrollment Completed

United States
Immune Control

Completed

Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Neurocrine Biosciences
Immune Tolerance Network (ITN)

Completed

Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

Multiple Sclerosis
Haukeland University Hospital
University of Bergen; Helse Stavanger HF; Helse Vest; Forskningsrådet; Folkehelse... and other collaborators

Active, not recruiting

Integrated Treatment of Hepatitis C Virus Infection (INTRO-HCV)

Hepatitis C, Chronic | Opioid Dependence, on Agonist Therapy

Norway
Natural Immune Systems Inc
New Chapter Inc.

Completed

Golden Black Seed: Support of Metabolic Health and General Wellness.

Hyperglycemia | Hyperlipidemias

United States
Tasly Pharmaceuticals, Inc.
Natural Immune Systems Inc

Unknown

Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

Glucose Metabolism Disorders

United States
Natural Immune Systems Inc
JBSL-USA Incorporated

Completed

Effects of NSK-SD (Nattokinase) on Blood Pressure

Hypertension

Clinical Trials Sponsored by Furesø Kommune

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations